STAT5B and acute promyelocytic leukemia: However, this mutation was identified in a chimeric protein of STAT5B and retinoic acid receptor-α (STAT5B-RARα), which is associated with acute promyelocytic leukemia (APL) and is also resistant to all-trans retinoic acid therapy.